Stocks got off to a slow start Wednesday but rose steadily throughout the session to close higher for a second consecutive day.
Lifting Wall Street's collective mood was a report from the Conference Board that showed consumer confidence – a gauge of how much Americans are willing to spend on goods and services – rose to 115.9 in December from November's reading at 111.9.
Meanwhile, the National Association of Realtors (NAR) said existing U.S. home sales jumped 1.9% month-over-month in November to a seasonally adjusted annual rate of 6.46 million units. Although the reading came in below the 2.5% increase expected by economists, it still puts existing home sales on track for their hottest year since 2006, according to NAR.
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
Adding to the bullish buzz was news the Food and Drug Administration issued emergency use authorization for Paxlovid, Pfizer's (PFE, +1.0%) pill to treat COVID-19, for high-risk patients 12 and over. Reports from South Africa – where the omicron variant was first detected – showing a 20% reduction in case counts from last week's peak also aided sentiment.
At the close, the Dow Jones Industrial Average was up 0.7% at 35,753, the S&P 500 Index was 1.0% higher at 4,696 and the Nasdaq Composite had gained 1.2% to 15,521.
Other news in the stock market today:
- The small-cap Russell 2000 rose 0.9% to 2,221.
- U.S. crude oil futures gained 2.3% to settle at $72.76 per barrel.
- Gold futures edged up 0.8% to finish at $1,802.20 an ounce.
- Bitcoin added 0.8% to $48,982.25. (Bitcoin trades 24 hours a day; prices reported here are as of 4 p.m.)
- Tesla (TSLA) stock jumped 7.5% after CEO Elon Musk said in a podcast interview with satirical website Babylon Bee that he sold "enough stock" to meet his plan to unload 10% of his ownership stake. In early November, Musk initiated a Twitter poll asking if he should sell 10% of his total holdings in Tesla. However, the sale of the shares may have already been in the cards, as the CEO had planned on exercising options granted to him as an insider, according to a mid-September Securities and Exchange Commissions (SEC) filing. From its Nov. 4 peak above $1,243 through yesterday's close at $899.94, TSLA stock shed nearly 28%.
- Olive Garden parent Darden Restaurants (DRI, +1.6%) was upgraded to Buy from Hold by Stifel analyst Chris O'Cull. "Shares declined following a strong earnings report last Friday, which we believe was driven by the concurrent announcement of CEO Gene Lee's retirement at the end of May," O'Cull wrote in a note. While he said he wasn't surprised by the reaction, he feels Lee's successor, Rick Cardenas, will continue to guide the company on a path of strategic growth. The analyst also acknowledged that "variant-related sales disruptions are a near-term risk," but believes the shares are trading at "an attractive entry point for a high-quality company."
Sure, There Will Be Risks in 2022, But Also Opportunities
If there's one thing the last two years have taught us, it's to be prepared.
"As we close out 2021, the world looks both different from a year ago and very much the same," says Brad McMillan, chief investment officer for independent broker-dealer Commonwealth Financial Network.
In addition to another wave of COVID-19 underway, rising inflation, supply-chain issues and a challenged global economic recovery create plenty of uncertainty for investors. "Indeed, these risks are still very real," adds McMillan. "But so are the opportunities – and 2022 is likely to see even further improvement from 2021."
The best way for investors to take advantage of these opportunities is to arm themselves with the best investments. You can find plenty of potential in our best stocks for 2022, as well as in our Kiplinger's Investing Outlook.
But stocks aren't the only way to prepare your portfolio for the new year, and exchange-traded funds (ETFs) are investing's Swiss Army knife. Whether you're looking to build a portfolio core, add defensive positions or even protect against market drops, our list of the 22 best ETFs for 2022 likely has something for you. Take a look.
-
Stock Market Today: Another Quarter, More Mixed Price Action"Up and to the right" remains the general trend despite persistent uncertainty around critical policy issues.
-
Over 100k Medicare Accounts Breached in Latest Hack: Was Yours One?Letters are going out to 103,000 Medicare beneficiaries who may have been impacted. Here's how to protect your identity and benefits.
-
Stock Market Today: Another Quarter, More Mixed Price Action
"Up and to the right" remains the general trend despite persistent uncertainty around critical policy issues.
-
Stock Market Today: A Historic Quarter Closes on High Notes"All's well that ends well" is one way to describe the second quarter of 2025, at least from a pure price-action perspective.
-
Stock Market Today: Stocks Swing as Trump Scraps Canada Trade TalksDespite a mid-afternoon slip, the S&P 500 and Nasdaq ended the day at new record highs.
-
Stock Market Today: S&P 500, Nasdaq Near New HighsThe S&P 500 hasn't hit a new high since February. It's been since December for the Nasdaq.
-
Stock Market Today: Stocks Struggle to Sustain GainsMixed messages from multiple sources continue to make for a messy market for investors, traders and speculators.
-
Stock Market Today: Stocks Soar on Israel-Iran CeasefireIt was a rocky start to the truce, but a temporary halt to fighting between Israel and Iran appears to be holding for now.
-
The Riskiest S&P 500 Stocks Right NowBuyer beware: These are five of the riskiest stocks in the S&P 500 at the moment, based on one measure of volatility.
-
Stock Market Today: Stocks Rise on a Little More UncertaintyThe best response to a major geopolitical event is often no response at all, especially if you're looking at the big picture.
